Pakistan Journal of Health Sciences,
Год журнала:
2024,
Номер
unknown, С. 288 - 295
Опубликована: Ноя. 30, 2024
The
Neutrophil
Percentage
to
Albumin
Ratio
(NPAR)
was
identified
as
a
promising
biomarker
for
identifying
inflammation
and
renal
complications
in
diabetic
Urinary
Tract
Infections
(UTIs).
Objective:
To
evaluate
the
diagnostic
potential
of
NPAR
novel
diagnosis
prognosis
UTIs.
Methods:
current
study
carried
out
according
PRISMA
criteria
determine
prognostic
value
(April
2024
June
2024)
made
on
Google
Scholar,
Science
Direct,
PubMed
with
date
ranging
from
2014
2024.
Articles
comparing
effect
non-diabetic
UTI-related
inflammation,
immune
cells
suppression,
comparison
classic
biomarkers
comorbidities
damage
were
taken
review.
Information
available
different
world
areas,
such
Asia
Pacific,
Europe,
America’s
breadth.
first
search
found
162
papers,
but
134
remained
after
duplicates
deleted,
these
screened
reviewed,
resulting
inclusion
15
studies
systematic
Results:
findings
demonstrated
that
has
higher
reliability
diagnosing
than
traditional
biomarkers,
especially
septic
patients
hypoalbuminemia.
Conclusions:
Due
reliability,
sensitivity
specificity
NPAR,
it
evaluating
UTI.
Its
implementation
part
clinical
practice
could
extend
understanding
disorder
early
identification.
KIM-1
can
be
upregulated
by
kidney
injury,
detectable
in
the
blood
during
early
DKD
stages
diabetic
patients,
including
those
without
albuminuria.
Therefore,
holds
value
for
diagnostic
strategies.
Diabetic
disease
(DKD)
affects
approximately
40%
of
patients
with
diabetes
globally
and
is
leading
cause
end-stage
(ESKD)
[1].
With
increasing
prevalence
recent
years,
has
become
a
major
public
health
challenge,
contributing
to
significant
healthcare
burdens.
Moreover,
compared
who
have
alone,
face
markedly
higher
risk
cardiovascular
significantly
increased
mortality
[2].
This
highlights
importance
diagnosis
manage
slow
progression,
prevent
severe
outcomes,
improve
overall
patient
prognosis.
develops
as
persistent
high
glucose
levels
damage,
inflammation,
glomerular
hyperfiltration,
fibrosis,
ultimately
resulting
nephron
loss
[3].
The
are
often
asymptomatic,
making
it
challenging
detect
before
damage
occurs.
As
progresses,
albumin
urine
becomes
evident,
representing
one
earliest
clinical
signs
disease.
A
primary
indicator
albumin-to-creatinine
ratio
(UACR)
An
elevated
UACR
indicates
permeability
filtration
barrier
renal
injury.
However,
limitation
its
inability
injury
non-albuminuric
DKD.
Research
shown
that
occur
urine,
8%–12%
cases
caused
type
2
mellitus
(T2DM)
do
not
present
albuminuria
[4].
Thus,
may
fail
identify
these
individuals.
Another
key
estimated
rate
(eGFR),
which
calculated
using
serum
creatinine
level
along
age,
sex,
race
estimate
kidneys'
filtering
capacity
eGFR
typically
remains
within
normal
ranges
until
substantial
occurred,
potentially
delaying
treatment
earlier,
more
treatable
[5].
based
on
abnormalities
two
above-mentioned
indicators,
while
excluding
other
potential
causes
chronic
disease—a
process
both
complex
time-consuming
identifying
specific
applicable
biomarkers
diverse
crucial
developing
simple
accurate
detection
method
improves
outcomes.
Several
indicators
been
investigated
tumor
necrosis
factor
receptor
1
(TNFR1)
Some
reportedly
indicate
occurrence
DKD,
trials
demonstrating
their
independent
association
development
Among
them,
molecule
(KIM-1)
shows
particular
promise.
produced
released
into
bloodstream,
easy
detect.
It
predict
progression
[6].
Additionally,
broadly
across
different
types
either
(T1DM)
or
T2DM.
emerged
promising
biomarker.
I
transmembrane
glycoprotein
primarily
expressed
apical
surface
proximal
tubular
epithelial
cells
kidney.
was
first
reported
Ichimura
et
al.
[7]
1998
novel
protein
following
main
structure
includes
immunoglobulin-like
variable
domain
(IgV),
highly
glycosylated
mucin
domain,
stalk
cytoplasmic
(Figure
1).
Under
conditions,
expression
low.
particularly
response
increases
significantly.
plays
role
clearing
apoptotic
further
IgV
binds
ligands
such
phosphatidylserine,
contains
tyrosine
kinase
phosphorylation
sites,
regulates
downstream
cell
signaling
pathways,
anti-inflammatory
responses,
autophagy,
survival.
stem
N-glycosylation
sites
susceptible
shedding
metalloproteinases.
allows
extracellular
portion
Consequently,
urinary
associated
acute
[8].
Structure
KIM-1.
domain.
IgV,
Ig-like
domain;
KIM-1,
molecule-1;
PS,
phosphatidylserine.
Nevertheless,
some
research
suggests
(Table
One
study
demonstrated
serve
an
warning
sign
decline,
patients.
upregulation
providing
opportunity
timely
identification
enabling
earlier-stage
intervention
traditional
markers.
In
2014,
Sabbisetti
[9]
found
were
T1DM.
cohort
124
T1DM
albuminuria,
correlated
advanced
Similarly,
report
Coca
[11]
2017,
ACCORD
cohort,
linked
decline.
included
190
pairs
T2DM,
each
pair
consisting
early-stage
progressed-stage
showed
progressed
had
baseline
than
These
findings
underscore
marker
at
interventions
could
ESKD.
(1)
relevant
(2)
predicts
ESKD
processing
risk.
strongly
progressive
function
decline
demonstrate
non-albuminuria
(3)
independently
TNFR-1,
TNFR-2
processed
stage
ones.
remained
TNFR-1
TNFR-2.
Further
supporting
detection,
Nowak
[10]
2016
among
259
203
microalbuminuric
77
healthy
individuals
diabetes.
results
no
difference
between
finding
even
T1DM—who
pose
challenge—elevated
plasma
predicted
because
subset
does
develop
rendering
methods
less
effective
ability
universal
biomarker
addressing
critical
gap
current
Beyond
predicting
progression.
Patients
likely
faster
declines
over
time.
5-
15-year
follow-up
[9],
63%
participants
above
median
(97
pg/mL)
ESKD,
only
20%
below
median.
predictive
capability
extends
utility
beyond
diagnosing
monitoring
informing
decisions.
studies
evaluating
multiple
biomarkers,
consistently
few
when
analyzed
collectively.
For
example,
T1DM,
irrespective
characteristics,
TNFR1
levels,
markers
damage.
tubules
contribute
non-proteinuric
[10].
provides
distinct
valuable
insights
complement,
rather
duplicate,
information
offered
biomarkers.
incorporating
protocols
precision
Although
promise
several
challenges
must
addressed
widely
used
practice.
First,
vary
populations
non-renal
factors
systemic
inflammation
comorbidities
elevate
reducing
specificity.
needed
assess
impact
establish
population-specific
reference
values,
ensuring
measurements
clinically
meaningful.
standardized,
reliable,
cost-effective
detecting
broader
adoption.
should
prioritize
sensitivity
specificity
being
practical
use
various
settings.
diagnosis,
critical.
enzyme-linked
immunosorbent
assay
chemiluminescent
immunoassay
limitations
speed,
low-concentration
missed
diagnoses
[12].
By
contrast,
nanoparticle-based
sensors
offer
sensitivity,
much
lower
concentrations.
accuracy
but
also
simplify
testing
small
size,
low
cost,
efficient
materials
(e.g.,
metal
nanoparticles,
quantum
dots).
Unlike
rely
expensive
equipment
procedures,
nanoparticle
integrated
portable
devices,
accessibility,
resource-limited
settings
[13].
enhancing
costs,
nanotechnology
solution
preventing
complications
from
delayed
diagnoses.
addition,
integrating
multi-biomarker
panels
prognostic
accuracy.
Combining
TNFR1,
TNFR,
cystatin
C
provide
complementary
insights,
single-biomarker
approaches,
atypical
[14].
Multi-biomarker
comprehensive
assessment
health,
facilitating
precise
stratification.
Finally,
dynamic
tool
warrants
investigation.
While
underexplored.
Long-term
clarify
relationship
well
how
fluctuate
therapeutic
[9].
Such
would
robust
evidence
marker,
application
challenges,
standardized
user-friendly
methods,
investigating
changes,
pivotal
management.
advancement
enhance
accuracy,
prognosis
assessment,
optimize
conclusion,
offering
benefits
proteinuric
To
fully
harness
KIM-1's
utility,
future
standardizing
user-friendly,
systems.
long-term
evaluate
Addressing
will
indispensable
management,
improving
Ningjie
Gong:
conceptualization
(equal),
data
curation
investigation
writing–original
draft
(equal).
Qian
Wang:
project
administration
visualization
Zhaoqing
Cong:
validation
Lezhi
Xu:
Wenqian
Yang:
Yang
Du:
supervision
authors
nothing
report.
declare
conflicts
interest.
Data
sharing
this
article
new
created
analyzed.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(5), С. 2063 - 2063
Опубликована: Фев. 27, 2025
Arterial
hypertension
and
diabetes
mellitus
are
components
of
the
cardiometabolic
syndrome
that
arises
from
a
sedentary
lifestyle,
excess
calorie
intake,
obesity.
Swietenia
humilis
Zucc
has
been
used
in
traditional
Mexican
medicine
for
treatment
mellitus;
this
work
investigated
antioxidant,
antidiabetic,
vasorelaxant
effects
ethanolic
extract
S.
seeds.
The
phytochemical
composition
was
analyzed
by
high-performance
liquid
chromatography.
To
study
hypoglycemic
effect,
activity
antioxidant
enzymes
(catalase,
superoxide
dismutase,
glutathione
peroxidase)
markers
oxidative
stress
(malondialdehyde
8-hydroxy-2-desoxyguanosine)
were
evaluated
model
induced
nicotinamide
streptozotocin
rats.
vasodilatory
effect
tested
rat
aortic
rings.
seeds
showed
hypoglycemic,
endothelium-independent
effects,
probably
blocking
calcium
transport,
likely
due
to
ursolic
acid
α-amyrin,
compounds
more
abundant
extract.
Journal of Health Population and Nutrition,
Год журнала:
2025,
Номер
44(1)
Опубликована: Март 13, 2025
Abnormal
kidney
function
is
associated
with
adverse
outcomes
in
patients
type
2
diabetes
mellitus
(T2DM).
However,
the
evidence
between
and
mortality
among
Chinese
T2DM
were
still
limited.
This
cohort
study
included
19,919
participants
baseline
from
2013
to
2014
Jiangsu,
China.
Serum
estimated
glomerular
filtration
rate
(eGFR),
urea,
uric
acid
measured
at
baseline,
Cox
regression
models
used
evaluate
hazard
ratios
(HRs)
95%
confidential
intervals
(95%CIs)
of
all-cause
cause-specific
mortality.
Restricted
cubic
splines
analyze
dose-response
relationships,
we
explored
best
cut-off
values
by
receiver
operating
characteristic
(ROC)
curves.
During
a
median
follow-up
9.77
years,
4,428
deaths
occurred,
including
1,542
(34.8%)
due
cardiovascular
disease
(CVD),
1,074
(24.3%)
cancer.
Compared
lowest
quintile
level
(Q1),
highest
(Q5)
eGFR
was
negatively
(HR
=
0.67,
95%CI:
0.58–0.77)
CVD
0.57,
95%CI
0.44–0.75).
The
higher
levels
urea
positively
(Q5
vs.
Q1:
HR
1.27,
1.16–1.39;
1.21,
1.10–1.34),
an
overall
"U-shaped"
relationships.
Moreover,
cancer
0.79,
0.66–0.95).
88.50
ml/min/1.73m2,
6.95
mmol/L
342.50
µmol/L
for
eGFR,
acid,
respectively.
We
found
abnormal
people
T2DM.
More
clinical
researches
are
needed
validate
effects
on
risk
prevention
management.
Diabetic
kidney
disease
(DKD)
is
a
serious
consequence
of
diabetes
mellitus
(DM).
If
not
managed
effectively,
DKD
often
develops
into
end-stage
renal
(ESRD).
The
most
successful
treatment
for
ESRD
transplantation,
offering
improved
quality
life
and
survival
rates.
For
insulin-dependent
diabetic
patients
with
ESRD,
simultaneous
pancreas-kidney
transplantation
(SPKT)
offers
alternative
that
treats
both
failure
the
underlying
diabetes.
However,
SPKT
involves
more
complicated
surgery,
prolonged
operative
time,
higher
risk
complications.
This
review
aims
to
highlight
impact
DM
on
transplant
recipients
(KTRs)
regarding
post-transplant
complications,
graft
survival,
mortality
rates,
role
glucose-lowering
medications
immunosuppressants.
incidence
urinary
tract
infections,
cardiovascular
foot
was
among
KTRs.
A
decrease
in
rate
at
five
years
observed
diabetics
compared
non-diabetics,
similar
rates
type
1
2
DM.
notably
patients,
complications
being
leading
cause.
emergence
new-onset
post-transplantation
(NODAT)
significant
cause
concern.
Certain
factors,
including
family
history
DM,
age
>45
years,
obesity,
male
gender,
immunosuppressive
medications,
have
been
linked
this
phenomenon.
Immunosuppression
substantial
challenge
as
certain
such
tacrolimus
shown
be
considerably
diabetogenic
cyclosporine
belatacept,
it
also
postulated
corticosteroids
can
lead
hyperglycemia.
Some
studies
proved
insulin
degludec,
glucagon-like
peptide-1
receptor
agonists,
thiazolidinediones,
sodium-glucose
cotransporter
inhibitors,
are
safe
effective
these
debatable
low
confidence.
Hence,
imperative
conduct
large
clinical
trials
establish
definitive
guidelines
manage
pre-existing
NODAT
KTRs
multidisciplinary
care
help
clinicians
improve
patient
outcomes.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Апрель 11, 2025
Diabetic
kidney
disease
(DKD)
is
the
primary
cause
of
end-stage
renal
disease.
This
study
examines
diagnostic
efficacy
multi-modal
ultrasound
imaging
technology
for
early
detection
DKD,
offering
a
valuable
reference
prompt
diagnosis
affected
patients.
The
clinical
data
88
patients
with
early-stage
type
2
diabetic
(E-T2DKD
group),
82
uncomplicated
diabetes
(T2DM
and
healthy
individuals
(control
group)
who
underwent
physical
examinations
at
outpatient
clinic
Affiliated
Jiangning
Hospital
Nanjing
Medical
University,
were
analyzed.
Multimodal
(MUIT)
was
employed
to
detect
various
parameter
indicators,
prediction
model
developed
using
receiver
operating
characteristic
(ROC)
curve.
results
indicated
no
significant
differences
in
age,
gender,
BMI
among
three
patient
groups.
In
comparison
T2DM
group,
those
E-T2DKD
group
exhibited
significantly
higher
durations
HbA1C
levels.
Significant
observed
function-related
indicators
assessed
across
groups,
including
Cystatin
C,
β2-microglobulin
(β2-MG),
serum
retinol-binding
protein
(S-RBP),
creatinine
(Scr),
plasma
urea
nitrogen
(PUN),
estimated
glomerular
filtration
rate
(eGFR),
urine
neutrophil
gelatinase-associated
lipocalin
(U-NGAL),
(U-RBP),
N-acetyl-β-D-glucosaminidase
(U-NAG)
urinary
albumin
excretion
rates
(UAER)
(p
<
0.05),
whereas
found
eGFR,
Scr
PUN
levels
between
control
group.
Notable
statistical
groups
also
identified
MUIT
parameters,
cortex
shear
wave
elastography
(SWE),
volume
index
(KVI),
interlobar
artery
(IA)
Vsmax,
IA
Vdmin,
resistance
(RI),
pulsatility
(PI)
0.05).
SWE,
KVI,
RI,
PI
than
both
while
RCT/RMT,
Vdmin
lower
These
incorporated
into
binary
logistic
regression
model,
joint
predictive
value
fitted
based
on
coefficients.
Further
ROC
analysis
revealed
that
area
under
curve
(AUC)
characteristics
reached
0.993,
indicating
high
E-T2DKD.
BMC Endocrine Disorders,
Год журнала:
2025,
Номер
25(1)
Опубликована: Апрель 18, 2025
Extensive
evidence
suggests
that
dyslipidemia
is
associated
with
endothelial
dysfunction,
oxidative
stress,
and
inflammation,
all
of
which
can
contribute
to
kidney
dysfunction.
The
atherogenic
index
plasma
(AIP)
a
novel
marker
lipid
metabolism
disorder,
but
its
role
in
dysfunction
diabetic
individuals
remains
controversial.
This
study
aims
clarify
the
association
AIP
individuals.
cross-sectional
analyzed
representative
sample
participants
aged
20
years
older
from
United
States
(n
=
2,386,
NHANES
2007-2018)
Korea
698,
KNHANES
2012).
Weighted
multivariate
logistic
regression
analyses
smoothed
curve
fitting
were
conducted
investigate
relationship
between
logarithmically
transformed
(lgAIP)
multiple
including
albuminuria
low
estimated
glomerular
filtration
rate
(eGFR)
Additionally,
we
interaction
subgroup
assess
whether
this
remained
consistent
across
different
populations.
We
utilized
receiver
operating
characteristic
(ROC)
curves
compare
diagnostic
performance
other
indices
for
In
both
databases,
higher
lgAIP
was
significantly
occurrence
(NHANES:
OR
7.69,
95%CI:
2.90-20.40;
KNHANES:
6.00,
1.05-34.36)
fully
adjusted
model.
However,
(95%
CI)
low-eGFR
1.22
(0.33,
4.53)
database
2.50
(0.16,
38.62)
database,
indicating
no
statistically
significant
association.
Subgroup
analysis
revealed
influenced
by
age
BMI
stratification
(p
<
0.05).
Compared
indicators,
appears
be
more
precise
discriminatory
predicting
Our
findings
highlight
strong
Future
research
should
explore
mechanisms
underlying
relationship.
Not
applicable.
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(4), С. 293 - 293
Опубликована: Апрель 21, 2025
The
progression
of
type
2
diabetes
is
associated
with
multiple
complications,
one
which
diabetic
nephropathy
(DN).
This
study
aimed
at
investigating
the
nephroprotective
potential
two
doses
150
mg/kg
and
300
Tanacetum
balsamita
leaf
extract
(ETB)
on
metabolic-induced
renal
injury
(MIRI)
in
rats.
Markers
oxidative
stress
antioxidant
defense,
histopathology,
serum
biochemistry,
urinalysis
were
measured.
Blood
glucose
level
arterial
blood
pressure
assessed
weekly
for
experimental
period
eight
weeks.
ETB
a
high
dose
significantly
decreased
levels
mildly
lowered
systolic
In
kidney,
restored
marker
malondialdehyde,
reduced
glutathione,
markedly
increased
enzymatic
activity
related
to
GSH
turnover
by
46%
(GPx),
22%
(GR),
32%
(GST),
96%
(SOD).
elevated
urea
creatinine
alleviated
proteinuria
along
other
parameters.
Histopathological
examination
kidney
supported
observed
protective
effects.
Both
ameliorated
most
investigated
parameters
similarly
positive
controls
enalapril
acarbose.
benefits
MIRI-induced
damages
could
be
mono-
dicaffeoylquinic
acids
together
series
methoxylated
flavones
flavonols,
may
hold
significance
its
antidiabetic
activity.